Biobeat
Tel Aviv, Israel· Est.
Cuff‑less, AI‑enabled 24‑hour blood‑pressure monitoring for hypertension care.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Cuff‑less, AI‑enabled 24‑hour blood‑pressure monitoring for hypertension care.
CardiovascularHypertension
Technology Platform
Patented PPG‑based cuff‑less chest patch with AI algorithms that continuously derive blood‑pressure values and generate automated clinical reports.
Opportunities
Expansion into broader cardiovascular remote monitoring, integration with telehealth platforms, and securing reimbursement across US and EU markets.
Risk Factors
Intense competition from established ABPM manufacturers, reliance on payer adoption, and need for ongoing clinical validation to sustain market trust.
Competitive Landscape
Competes with traditional cuff‑based ABPM providers (e.g., Omron, Spacelabs) and emerging wearable firms (e.g., Withings, Philips), differentiating through cuff‑less chest‑patch comfort, AI‑driven analytics, and rapid report generation.